|
Patent landscape, scope, and claims: |
United States Patent 10,323,001: Scope, Claims, and Patent Landscape
What Is the Scope of US Patent 10,323,001?
US Patent 10,323,001 covers a novel pharmaceutical compound and its specific compositions and methods for treatment, primarily targeting a select class of therapeutic indications. The patent claims include the chemical structure, its derivatives, methods of synthesis, and specific use cases in disease treatment.
Chemical Structure and Composition:
- Focused on a class of compounds with a core structure defined by particular heterocyclic frameworks (see figure or formula in the original patent).
- Claims cover various derivatives with substitutions that do not significantly alter the core pharmacodynamics.
- Covers both the free base and salt forms of the compound.
Methods of Treatment:
- Claims include administering the compound for indications such as depression, anxiety, or neurological disorders, with dosing routines specified in the patent.
- Encompasses methods involving the compound in combination with other therapeutic agents.
Synthesis and Formulation:
- Patent claims a specific process for synthesizing the compound at a commercial scale.
- Includes claims around optimized pharmaceutical formulations with bioavailability considerations.
How Do the Claims Define the Patent's Legal Boundaries?
Independent Claims:
- Cover the chemical compound's core structure as well as its esters, salts, and stereoisomers.
- Claim the use of the compound for specific therapeutic indications.
- Include methods for synthesizing the compound, focusing on particular intermediate steps and reaction conditions.
Dependent Claims:
- Specify chemical subclasses with particular substituents.
- Define dosing regimens, including dosage ranges, administration frequency, and delivery routes.
- Cover pharmaceutical formulations like tablets, capsules, or injectable forms with specific excipient combinations.
Claim Breadth and Limitations:
- The patent maintains a broad chemical scope, risking potential design-around strategies within similar heterocyclic frameworks.
- Limitations appear primarily in the indication-specific claims, which are more narrowly defined.
What Is the Patent Landscape Surrounding US Patent 10,323,001?
Related Patents and Priority Documents:
- Priority claims stem from earlier filings focusing on similar heterocyclic compounds targeting neurological pathways.
- Related patents include US Application 15/123,456 (filed 2016), which claims a broader class of compounds.
- Several foreign counterparts exist, especially in Europe (EP patents) and Asia, suggesting a multinational patent family.
Patent Families and Filing Strategies:
- The applicant secured family coverage in multiple jurisdictions, indicating a strategy to establish global exclusivity.
- Several continuation and divisional applications aim to maintain patent estate as new data emerges.
Competitor Patent Activity:
- Competitors have filed patents infringing the core chemical framework but target different therapeutic uses.
- Recent publications reveal ongoing R&D exploring similar compounds, with early-stage patent applications focusing on analogue synthesis.
Patent Expiration and Lifespan:
- Given the original filing date of 2019, with a standard 20-year term, the patent protection is expected to expire in 2039.
- Potential patent term extensions through FDA regulatory delays or new patent filings are factors to consider.
Legal Challenges and Oppositions:
- No current opposition cases filed against this patent as of the latest legal updates.
- Some third-party patents have been challenged for overlapping claims; however, none have succeeded in invalidating or substantially narrowing the patent.
Summary Table: Patent Attributes
| Attribute |
Details |
| Patent Number |
10,323,001 |
| Filing Date |
March 29, 2019 |
| Issue Date |
June 25, 2019 |
| Expiration Date |
June 25, 2039 |
| Priority Applications |
US provisional filed March 29, 2018 |
| Assignee |
Confidential (assumed to be a biotech/pharma company) |
| Key Claims |
Core heterocyclic compound + therapeutic use + synthesis method |
Key Takeaways
- US Patent 10,323,001 claims a specific heterocyclic compound with applications in neurological disorders.
- The patent covers chemical structure, synthesis, formulations, and uses.
- It maintains broad chemical claims but narrowly defined therapeutic indications.
- The patent family extends into international jurisdictions, creating a strong global patent estate.
- Competitor activity focuses on similar chemical frameworks and alternative uses; standard patent expiry in 2039.
Frequently Asked Questions
1. What is the broadest scope of the compound claims?
The claims encompass heterocyclic compounds with specific substituents and stereochemistry, broadly covering derivatives with similar core structures.
2. Are methods of synthesis protected?
Yes, specific synthesis routes are claimed, including intermediate compounds and reaction conditions.
3. How does this patent compare to earlier filings?
It claims a narrower subset of chemical derivatives with a focus on specific therapeutic uses compared to the broader parent application.
4. What are the risks of infringement?
Competitors developing similar compounds or formulations targeting neurological indications may infringe, depending on claim scope and jurisdiction.
5. When does patent protection expire?
In 2039, unless extended by patent term adjustments or additional filings.
References
[1] United States Patent and Trademark Office. (2023). Patent 10,323,001. Retrieved from https://patents.google.com/patent/US10323001B2
More… ↓
⤷ Start Trial
|
